Skip to main content

Table 2 Risks of incident heart failure and hospitalization for heart failure according to FLI changes

From: The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study

 

Events

Model 1

Model 2

Model 3

Model 4

HR

95% CI

P value

HR

95% CI

P value

HR

95% CI

P value

HR

95% CI

P value

iHF

 Non-NAFLD

4902

Ref.

  

Ref.

  

Ref.

  

Ref.

  

 Regressed NAFLD

326

1.507

1.348–1.686

 < 0.001

1.237

1.102–1.388

 < 0.001

1.219

1.087–1.368

 < 0.001

1.049

0.935–1.178

0.414

 Incident NAFLD

332

1.478

1.322–1.651

 < 0.001

1.326

1.181–1.489

 < 0.001

1.307

1.164–1.469

 < 0.001

1.150

1.024–1.292

0.018

 Persistent NAFLD

626

1.827

1.681–1.986

 < 0.001

1.619

1.471–1.782

 < 0.001

1.575

1.430–1.736

 < 0.001

1.316

1.194–1.450

 < 0.001

 Persistent NAFLD

626

Ref.

  

Ref.

  

Ref.

  

Ref.

  

 Regressed NAFLD

326

0.825

0.722–0.943

0.005

0.753

0.652–0.870

 < 0.001

0.752

0.650–0.869

 < 0.001

0.800

0.691–0.925

0.003

hHF

 Non-NAFLD

2,067

Ref.

  

Ref.

  

Ref.

  

Ref.

  

 Regressed NAFLD

129

1.408

1.179–1.682

 < 0.001

1.285

1.071–1.542

0.007

1.249

1.041–1.499

0.017

1.101

0.916–1.322

0.305

 Incident NAFLD

120

1.264

1.052–1.520

0.013

1.328

1.098–1.608

0.004

1.289

1.065–1.561

0.009

1.162

0.959–1.407

0.125

 Persistent NAFLD

263

1.822

1.603–2.072

 < 0.001

2.048

1.767–2.373

 < 0.001

1.939

1.671–2.251

 < 0.001

1.666

1.434–1.935

 < 0.001

 Persistent NAFLD

263

Ref.

  

Ref.

  

Ref.

  

Ref.

  

 Regressed NAFLD

129

0.773

0.626–0.954

0.017

0.607

0.484–0.760

 < 0.001

0.616

0.491–0.773

 < 0.001

0.645

0.514–0.810

 < 0.001

  1. CI confidence interval, HR hazard ratio, iHF incident heart failure, hHF hospitalized heart failure
  2. Model 1: Crude
  3. Model 2: Age, sex, and body weight
  4. Model 3: Model 2 + alcohol consumption, smoking, regular exercise, and income status
  5. Model 4: Model 3 + hypertension, diabetes mellitus, dyslipidemia, and estimated glomerular filtration rate